Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
Tagrisso (osimertinib) Disease area(s): Oncology Manufacturer(s): AstraZeneca 2024 Sales (USD): $6.58 billion Why it sold so well: In 2024, AstraZenecas EGFR-TKI Tagrisso registered $6.58 billion in global sales, reflecting a 13% year-over-year increase
Every lot is assayed by an independent laboratory and the certificate is published before the compound is listed
Not a magic pill These medications are designed to be taken alongside weight-loss interventions to improve your lifestyle and shouldnt be considered lifelong medications
Worked as advertised I have only been on this for a month and have lost 10lbs already
It works by supporting the bodys natural signaling related to growth hormone pathways (rather than replacing growth hormone directly)
US$ 28.32
US$ 23.17
US$ 28.84
US$ 28.54
